RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Agreed. Reviewing all the published info about KRM-II-81, I think it has a chance to be just that. When the CEO stated it really is "remarkable" drug, I believe that is a genuine belief based upon what preclinical work has been indicating. Being effective against various forms of pain indications as well as epilepsy provides many possible paths of development that is most suitable for the candidate. IMO, they have to be getting closer to completing all the IND enabling preclinicals they could want. Maybe the purpose is to understand truly how valuable this "remarkable" drug candidate is. Given past preclincial success and progress within the NIH program, surely BP is watching this one close. The silence and lack of attention to investors only adds to the mystique surrounding all this.